New research will detect signs of cancer before symptoms appear. The new method of blood tests is simple and noninvasive and can reveal eight different types of cancer, including cancers of the liver, pancreas and lung diseases.
Illus Photo Credit: Rebecca Zeffert/Flash90
A breakthrough in cancer research has been designed to detect early diagnosis of cancer. Researchers have developed this experimental blood test, by the name of CancerSEEK, that is able to identify eight different types of cancer and indicate the organ and location of a tumor throughout the body before symptoms appear. The experimental test costs about $500 and has been compared to tests such as colonoscopies, yet is understood to be less invasive, according to Science magazine.
The test was performed on 1,005 patients previously diagnosed with stages 1-3 cancer, such as ovarian, liver, stomach, pancreatic, esophagus, colon, lung and breast. The test identified the various types of cancer in 70% of the cases. Cases of ovarian cancer increased the success rate to 98%. However, cases of breast cancer decreased to 33% success rate.
The researchers behind the study are hoping this method will help patients detect problems early on, helping to overcome the disease and prevent it from getting worse. “The use of a combination of selected biomarkers for early detection has the potential to change the way we screen for cancer, and it is based on the same rationale for using combinations of drugs to treat cancers,” said Professor Nickolas Papadopoulos, professor of oncology and pathology at Johns Hopkins Hospital in Baltimore and one of the researchers of the study.
The researchers have emphasized the need for further extensive research before the test can become most effective for the general public. Many of the generally used blood tests, such as blood counts, blood protein testing, cancer marker tests and tumor cell tests, can diagnose cancers but cannot determine for certain whether or not the patient has cancer.